Immunological recovery with BIC/FTC/TAF: CD4 T-cell count and CD4/CD8 ratio as markers of response

The CD4/CD8 ratio is a crucial marker of immune dysregulation, immune senescence, and inflammation, predicting outcomes such as non-AIDS conditions and mortality. A low CD4/CD8 ratio is common in late HIV diagnoses, which remain frequent in Italy, where 58% of new cases occur with advanced immune su...

Full description

Saved in:

Bibliographic Details
Published in:	The New microbiologica Vol. 48; no. 1; p. 1
Main Authors:	Bono, Valeria, Marchetti, Giulia C
Format:	Journal Article
Language:	English
Published:	Italy 01.03.2025
Subjects:	Anti-HIV Agents - administration & dosage Anti-HIV Agents - therapeutic use CD4 Lymphocyte Count CD4-CD8 Ratio Emtricitabine - therapeutic use HIV Infections - drug therapy HIV Infections - immunology HIV Infections - virology HIV-1 - drug effects Humans Tenofovir - analogs & derivatives Tenofovir - therapeutic use Immunological recovery BIC/FTC/TAF CD4/CD8 ratio CD4 T-cell count
ISSN:	1121-7138
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!